YOLFTbeta
Kwangdong Phar

Kwangdong Phar

009290 · KO · Consumer Defensive / Packaged Foods

6,270.00KRW-60.00 (-0.95%)

Price History

Full chart

Market Stats

Previous Close6,330.00
Open6,330.00
Day Range6,250.00 – 6,520.00
52-Week Range5,150.00 – 12,652.70
Volume266.97K
Market Cap325.55B
P/E (TTM)0.00
Forward P/E8.19
Dividend Yield1.52%
Beta0.36
50-Day Avg6,267.20
200-Day Avg6,889.85

About

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vitamin, mineral or vital energy substance and quasi drugs. In addition, it provides blackberry, ginger lonicerae flos, vita gold, and red ginseng gold drinks, as well as offers water, mixed drinks, tea drinks, and other drinks; and traditional health foods. The company offers its products through operation of TV, radio, and print advertising. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Sung-Won Choi
  • Employees1.00K
  • HeadquartersGasan Building, Seoul, South Korea, Korea
  • Websitehttps://www.ekdp.com

Leadership

  • Mr. Hyun-Sik KimPresident and Director · b. 1954
  • Mr. Kwa-Kyun MoPresident and Director · b. 1965
  • Mr. Sung-Won ChoiChairman & CEO · b. 1969
  • Mr. Ju-Hoon AhnSenior Managing Director and Director · b. 1966

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue313.99B332.64B468.38B522.27B955.45B1.06T1.14T1.18T1.24T1.24T1.34T1.43T1.51T1.64T1.66T
Growth (%)-+5.94%+40.81%+11.51%+82.94%+10.57%+8.06%+3.39%+4.92%+0.45%+7.59%+6.98%+5.79%+8.34%+1.15%
Cost of Revenue173.06B191.39B292.29B322.63B724.95B808.72B894.46B938.63B979.59B986.06B1.06T1.15T1.21T1.34T1.36T
Gross Profit--168.34B190.72B230.50B247.71B247.11B241.59B258.67B257.71B274.25B282.05B299.83B299.30B301.18B
Gross Margin--35.94%36.52%24.12%23.45%21.65%20.47%20.89%20.72%20.49%19.70%19.80%18.24%18.15%
Operating Expense--123.95B140.26B179.63B203.32B211.37B207.65B216.86B211.12B229.32B243.80B257.76B269.20B270.14B
Operating Income40.42B36.34B44.39B50.46B50.87B44.39B35.74B33.94B41.80B46.59B44.94B38.24B42.07B30.10B31.05B
Operating Margin12.87%10.92%9.48%9.66%5.32%4.20%3.13%2.88%3.38%3.75%3.36%2.67%2.78%1.83%1.87%
EBITDA------51.15B51.63B58.75B85.20B50.98B54.04B68.83B82.13B60.05B
EBITDA Margin------4.48%4.37%4.74%6.85%3.81%3.78%4.54%5.01%3.62%
Net Income29.92B27.82B22.04B35.04B35.02B28.06B23.20B22.35B23.06B45.37B24.02B24.17B36.97B40.48B20.97B
Net Income Margin9.53%8.36%4.70%6.71%3.66%2.66%2.03%1.89%1.86%3.65%1.79%1.69%2.44%2.47%1.26%
R&D-5.36B-5.90B1.51B1.51B1.51B4.18B5.34B5.96B8.32B9.68B15.27B10.13B9.13B
R&D as % of Total Revenue-1.61%-1.13%0.16%0.14%0.13%0.35%0.43%0.48%0.62%0.68%1.01%0.62%0.55%
Interest Expense00000002.78B3.18B2.54B2.54B3.74B6.90B10.27B11.01B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.24%0.26%0.20%0.19%0.26%0.46%0.63%0.66%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets321.68B389.43B425.68B442.53B663.79B679.78B722.70B732.06B792.78B830.64B883.85B932.02B1.08T1.17T1.32T
Total Liabilities72.16B122.16B134.85B128.13B286.06B280.10B306.40B301.22B345.32B328.46B356.60B384.98B490.02B552.01B608.53B
Total Equity248.12B266.02B289.27B312.79B349.95B372.99B391.89B405.32B422.96B477.66B499.18B517.33B544.62B579.12B655.58B
Cash19.63B36.18B36.74B39.17B36.91B42.69B47.60B67.48B76.28B54.88B83.97B103.55B77.34B116.19B140.99B
Net Debt------62.66B34.14B32.03B53.12B45.97B31.42B153.72B161.67B144.93B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow27.68B23.74B34.39B32.75B41.14B28.80B23.46B53.10B29.29B22.83B54.94B62.82B-11.73B-12.15B82.34B
Investing Cash Flow---20.36B-23.02B-68.34B-18.94B-24.13B-20.36B-17.79B-47.56B-42.98B-42.75B---
Financing Cash Flow-33.55B-13.38B-7.27B24.92B-4.31B6.66B-13.08B-3.21B3.84B15.89B-628.26M---
Capital Expenditure28.19B31.24B6.89B18.41B27.33B18.14B14.07B18.83B12.64B5.26B23.80B25.38B35.16B77.79B26.38B
Free Cash Flow------5.37B33.95B16.60B17.53B30.49B36.78B-46.89B-89.95B55.96B
Dividends Paid2.23B2.13B2.45B2.88B3.21B3.25B3.25B3.25B3.21B3.17B4.11B4.11B4.11B4.01B3.93B
FCF to OCF------22.89%63.94%56.69%76.77%55.50%58.55%399.72%740.09%67.97%
Dividend Paid to FCF------60.44%9.56%19.36%18.07%13.47%11.17%-8.76%-4.46%7.02%

Earnings

Report DateMay 15, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Feb 18, 2016May 16, 2016Aug 15, 2016Nov 11, 2016Mar 9, 2017May 15, 2017Aug 11, 2017Nov 14, 2017Mar 8, 2018May 15, 2018Aug 14, 2018Nov 13, 2018Mar 21, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 12, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Feb 15, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Feb 21, 2022May 10, 2022Aug 12, 2022Nov 11, 2022Mar 16, 2023May 12, 2023Aug 11, 2023Nov 10, 2023Mar 26, 2024May 13, 2024Aug 9, 2024Nov 8, 2024Feb 24, 2025May 13, 2025Aug 11, 2025Nov 11, 2025Feb 23, 2026May 12, 2026Jun 30, 2026
EPS Estimate174.48------------------------------------------------------
EPS Actual119.46140.6317.02250.61130.00165.28231.33282.13191.00197.24274.66248.21147.29196.50236.62206.2252.20155.3293.96252.5470.00178.89119.00210.6842.11228.93186.04103.5262.18270.00272.00742.00-165.29149.7856.91217.39160.28184.6873.03156.79173.95341.87210.48220.32138.05454.0933.01219.97304.2795.4063.82274.6187.2788.2354.24
Surprise-31.53%------------------------------------------------------
TimingAfter-hours-----------Pre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market---Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap325.55B
Enterprise Value440.82B
Trailing P/E0.00
Forward P/E8.19
PEG Ratio0.00
Price / Sales0.19
Price / Book0.50
Revenue (TTM)1.71T
Gross Profit (TTM)311.62B
EBITDA54.07B
Profit Margin1.28%
Operating Margin0.64%
Return on Equity3.46%
Return on Assets1.68%
Shares Outstanding49.70M
Shares Float42.64M
Beta0.36
Dividend Yield1.52%
Dividend Rate100.00
Payout Ratio19.83%

Dividends

20261×
100.00Mar 31, 2026
20251×
100.00Mar 31, 2025
20231×
100.00Dec 27, 2023
20221×
100.00Dec 28, 2022
20211×
100.00Dec 29, 2021
20201×
100.00Dec 29, 2020
20191×
80.00Dec 27, 2019
20181×
80.00Dec 27, 2018
20171×
80.00Dec 27, 2017
20161×
80.00Dec 28, 2016
20151×
80.00Dec 29, 2015
20141×
80.00Dec 29, 2014
20131×
70.00Dec 27, 2013
20121×
60.00Dec 27, 2012
20111×
50.00Dec 28, 2011
20101×
50.00Dec 29, 2010
20091×
50.00Dec 29, 2009
20081×
50.00Dec 29, 2008
20071×
60.00Dec 27, 2007
20061×
50.00Dec 27, 2006
20051×
50.00Dec 28, 2005
20041×
30.00Dec 29, 2004
20031×
20.00Dec 29, 2003
20021×
20.00Dec 27, 2002

Stock Splits

  • Jul 1, 1999884:825
  • Apr 26, 19995:1
  • Feb 10, 199921:20
  • Jan 4, 1999980:937
  • Sep 2, 19981169:1084
  • Sep 3, 1997689:664
  • Dec 13, 199511:10